Resource Centre

Discover a wealth of knowledge and insights from the experts at StarFish Medical. Our Resource Centre offers product development tips, reviews of new and cutting-edge technologies, and in-depth articles on regulatory updates and compliance in medical device development.

Archive Filters
Actions
  • Close-up of gloved hands holding a blue laboratory microtube rack with small clear sample tubes. The background shows a blurred laboratory setting, suggesting a scientific environment. Overlaid text reads 'Beyond Blood: NEW Testing Methods' in bold purple and gray font, highlighting the theme of alternative diagnostic sampling techniques.

    Bio Break: Exploring Alternative Bodily Fluids for Diagnostics

    In this episode of Bio Break, StarFish Medical experts Joris and Nick tackle an intriguing question: can alternative bodily fluids like sweat, saliva, or urine offer viable alternatives to blood sampling for medical diagnostics? While blood remains the gold standard for clinical testing, advancements in non-invasive sampling methods are opening new possibilities, particularly in wearable devices and at-home diagnostics.

  • A serene forest illuminated by numerous glowing fireflies, symbolizing the inspiration nature provides for innovations in medical diagnostics. Text overlaid on the image reads: "Nature-inspired Diagnostics" in bold purple and white fonts.

    Bio Break: How Nature-Inspired Biosensors Are Revolutionizing Medical Devices

    In this episode of Bio Break, Nick and Joris dive into the fascinating realm of biosensors, showcasing how nature’s biological processes inspire groundbreaking innovations in medical device technology. From jellyfish to fireflies, the natural world has provided invaluable tools that are transforming diagnostics and research.

  • A syringe aimed at the center of a black-and-white target, symbolizing precision. The text overlay reads "Precision Drug Activation" with a blurred laboratory background.

    Bio Break: Drug Activation Devices

    In this episode of Bio Break, Joris van der Heijden and Nick Allan discuss an advanced category of combination devices: drug activation devices. Unlike drug delivery devices that transport medication to specific locations, drug activation devices ensure the drug becomes active precisely where it is needed in the body, reducing systemic side effects and enhancing therapeutic effectiveness.

  • A healthcare professional wearing a surgical mask and scrubs holds a clipboard with a checklist partially completed. The text overlay reads "Clinical Trials: Expert Insights" in bold purple and gray lettering, emphasizing expertise and precision in clinical trial processes. The image suggests a focus on medical research and the methodology behind clinical studies.

    Bio Break: Understanding Clinical Trials – Key Steps and Expert Insights

    In this engaging episode of Bio Break, Nick and Joris dive into the complexities of clinical trials as a critical component of medical product development. Whether you’re a developer embarking on your first trial or a seasoned professional seeking guidance, this discussion provides actionable insights and resources to streamline the process.

  • Drug Delivery Devices for Cell and Gene Therapies

    5 Drug Delivery Solutions for Cell and Gene Therapy (CGT) Challenges

    Drug Delivery Solutions for Cell and Gene Therapy (CGT) Challenges explores effective delivery devices and solutions for advanced CGT therapies and their unique challenges.

  • Drug Delivery System Imaging - MRI image that can be used to direct treatments to specific parts of the brain

    Choosing a Drug Delivery System Imaging Technology

    Drug Delivery System Imaging Technology options include MRI, CT, and Ultrasound. This article highlights advantages and disadvantages for each technology in guiding drug delivery.

  • An illustrated concept of assay development featuring a blurred laboratory background with a focus on a magnifying glass emphasizing the text 'LOQ vs. LOD Explained.' The image also includes an upward-pointing arrow symbolizing progress and precision in diagnostics and analytics.

    Bio Break: Understanding Limit of Detection and Limit of Quantification in Assay Development

    Dive into the world of assay development with this informative episode of Bio Break, where Nick and Joris explore two critical concepts: Limit of Detection (LOD) and Limit of Quantification (LOQ). These terms might sound similar, but their implications for clinical diagnostics and medical devices are vastly different. Whether you’re an engineer, researcher, or product developer, this video sheds light on why both LOD and LOQ are vital in ensuring the precision and reliability of diagnostic tests.

  • A medical vial with liquid and several teal-and-white capsules floating in the air, with a text overlay reading "Drug & Device: Why combine?" in a lab setting background.

    Bio Break: Drug-Device Combination Products

    In this episode of Bio Break, Joris and Nick explore the increasingly important world of drug-device combination products, discussing what they are, why they matter, and the unique challenges associated with their development. As modern pharmaceuticals become more complex, the role of engineered medical devices in delivering these therapies safely and effectively has never been more critical.

  • An illustrated flow diagram with interconnected boxes, representing platform technologies in a modern office setting. The title 'Platform Technologies Pros & Cons' is displayed prominently in bold purple and green text, suggesting an exploration of benefits and challenges in the field.

    Bio Break: Pros and Cons of Platform Technologies in Medical Device Development

    In this engaging episode of Bio Break, Nick and Joris dive into the complex world of platform technologies in product development, exploring the pros and cons of this widely discussed concept. From in-vitro diagnostics to point-of-care instruments, the term “platform” often sparks excitement—and sometimes hesitation. But what does it truly mean to build a platform-based product, and when does it make sense?